Review



rock inhibitor y 27632  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    MedChemExpress rock inhibitor y 27632
    Rock Inhibitor Y 27632, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 712 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rock+inhibitor+y+27632/Y-27632/pm42363275-108-5-8
    Average 99 stars, based on 712 article reviews
    rock inhibitor y 27632 - by Bioz Stars, 2026-09
    99/100 stars

    Images

    Related Articles

    other:

    Article Title: Miniature and versatile genome regulation TnpB-ωRNA toolkits facilitate cancer immunotherapy.
    Article Snippet: The tissues were digested at 37 °C for 30 minutes in Advanced DMEM/F-12 supplemented with collagenase type II (Worthington), DNase I (Worthington), and the ROCK inhibitor Y-27632 (MCE, HY-10071).

    Article Title: Local IFNγ signaling contributes to the regenerative decline of aged alveolar progenitor cells
    Article Snippet: The ROCK inhibitor Y-27632 (HY-10583, MCE, USA) was used in the first 4 days of organoid culture and the medium was exchanged every 2-3 days.

    Article Title: Farnesyltransferase inhibitor LB42708 disables oncogenic RAS signaling and overcomes gefitinib resistance in NSCLC via FTase α-subunit and RAS degradation.
    Article Snippet: The filtered cells were then centrifuged at 112 × g for 3 min, and the resulting pellet was resuspended in 100 μL of minimum basal medium (MBM), which consisted of serum-free DMEM/F12 supplemented with 20 ng/mL of bFGF (BD Biosciences, San Jose, CA, USA), 50 ng/mL of rhEGF (BD Biosciences, San Jose, CA, USA), N2 Supplement (Invitrogen, Waltham, MA, USA), B27 (Invitrogen, Waltham, MA, USA), 10 μM ROCK inhibitor Y-27632 (MCE, Shanghai, China), and 1% penicillin/streptomycin (Thermo Fisher Scientific, Waltham, MA, USA).

    Article Title: Miniature and versatile genome regulation TnpB-ωRNA toolkits facilitate cancer immunotherapy
    Article Snippet: The tissues were digested at 37 °C for 30 min in advanced DMEM/F-12 supplemented with collagenase type II (Worthington), DNase I (Worthington), and the ROCK inhibitor Y-27632 (MCE, HY-10071).

    Article Title: Proteomics-based approach reveals the involvement of spliceosomal components SF3B and SerpinB9 in dermatofibrosarcoma protuberans.
    Article Snippet: In addition, 4 μM of ROCK inhibitor Y-27632 (MCE) was added in the culture medium to maintain tumor stemness.

    Article Title: Mitotic errors drive rapid clearance of polyploidy during intestinal regeneration despite robust centrosome clustering
    Article Snippet: In monolayer culture, 10 μM ROCK inhibitor Y-27632 (HY-10583, MedChemExpress) was added to the culture medium.

    Article Title: Artificial intelligence-driven high-content imaging decodes for NLRP7-mutant recurrent hydatidiform moles
    Article Snippet: Following each passage, the culture medium was supplemented with 10 μM of the ROCK inhibitor Y-27632 (MedChemExpress, HY-10071) for approximately 24 h. Subsequently, the medium was replaced with fresh mTeSR1 lacking Y-27632.

    Cell Culture:

    Article Title: p62/SQSTM1 Condensation Modulates Mitochondrial Clustering to Participate in Mitochondrial Quality Control.
    Article Snippet: .. The human iPSCs (National Collection of Authenticated Cell Cultures) were cultured in mTeSR1 medium (StemCell Technologies, 85850) supplemented with 10 μM ROCK inhibitor Y- 27632 (MedChemExpress) on Matrigel- coated dishes. .. For neuronal differentiation modified by STEMdiff Differentiation Kit, iPSCs were dissociated with Accutase (Corning) and centrifuged at 300 g for 5 min.



    Similar Products

    rock inhibitor y 27632  (MedChemExpress)
    99
    MedChemExpress rock inhibitor y 27632
    Rock Inhibitor Y 27632, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rock+inhibitor+y+27632/Y-27632/pm42363275-108-5-8
    Average 99 stars, based on 1 article reviews
    rock inhibitor y 27632 - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    y27632 rock inhibitor  (MedChemExpress)
    99
    MedChemExpress y27632 rock inhibitor
    Y27632 Rock Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rock+inhibitor+y+27632/Y-27632/bio_rxiv__64898__2026__06__24__734338-138-76-79
    Average 99 stars, based on 1 article reviews
    y27632 rock inhibitor - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    rock inhibitor  (MedChemExpress)
    99
    MedChemExpress rock inhibitor
    Morphological changes of UG-LIKE structures in collagen I-supplemented Matrigel, with or without the allosteric collagen <t>I-binding</t> <t>integrin</t> inhibitor and <t>ROCK</t> inhibitor. Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0, 0.1, or 0.5 mg/ml bovine collagen I ( N = 5, mean ± SEM). Different superscripts indicate significant differences among collagen I concentrations, as determined by one-way ANOVA of logit-transformed data ( P < 0.05). Scale bars represent 1000 μm (A). Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0 or 0.5 mg/ml bovine collagen I, with or without 0, 10, or 50 μM allosteric collagen I-binding integrin inhibitor (TC-l 15) ( N = 5, mean ± SEM). Different superscripts indicate significant differences among experimental groups, combining collagen I supplementation and TC-l 15 treatment as a single factor, as determined by one-way ANOVA of logit-transformed data ( P < 0.05). Scale bars represent 1000 μm (B). Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0 or 0.5 mg/ml bovine collagen I, in the presence or absence of 0 or 10 μM ROCK inhibitor (Y-27632) ( N = 5, mean ± SEM). Different superscripts indicate significant differences among experimental groups, with collagen I supplementation and Y-27632 treatment as two independent factors, as determined by two-way ANOVA of logit-transformed data (Supplementary Table S4, P < 0.05). Scale bars represent 1000 μm (C).
    Rock Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rock+inhibitor+y+27632/Y-27632/pmc13259824-104-30-34
    Average 99 stars, based on 1 article reviews
    rock inhibitor - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    rock inhibitor y 27632  (Nacalai)
    86
    Nacalai rock inhibitor y 27632
    Morphological changes of UG-LIKE structures in collagen I-supplemented Matrigel, with or without the allosteric collagen <t>I-binding</t> <t>integrin</t> inhibitor and <t>ROCK</t> inhibitor. Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0, 0.1, or 0.5 mg/ml bovine collagen I ( N = 5, mean ± SEM). Different superscripts indicate significant differences among collagen I concentrations, as determined by one-way ANOVA of logit-transformed data ( P < 0.05). Scale bars represent 1000 μm (A). Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0 or 0.5 mg/ml bovine collagen I, with or without 0, 10, or 50 μM allosteric collagen I-binding integrin inhibitor (TC-l 15) ( N = 5, mean ± SEM). Different superscripts indicate significant differences among experimental groups, combining collagen I supplementation and TC-l 15 treatment as a single factor, as determined by one-way ANOVA of logit-transformed data ( P < 0.05). Scale bars represent 1000 μm (B). Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0 or 0.5 mg/ml bovine collagen I, in the presence or absence of 0 or 10 μM ROCK inhibitor (Y-27632) ( N = 5, mean ± SEM). Different superscripts indicate significant differences among experimental groups, with collagen I supplementation and Y-27632 treatment as two independent factors, as determined by two-way ANOVA of logit-transformed data (Supplementary Table S4, P < 0.05). Scale bars represent 1000 μm (C).
    Rock Inhibitor Y 27632, supplied by Nacalai, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rock+inhibitor+y+27632/27632+y/pm42289321-59-8-11
    Average 86 stars, based on 1 article reviews
    rock inhibitor y 27632 - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    y 27632 rock inhibitor  (MedChemExpress)
    99
    MedChemExpress y 27632 rock inhibitor
    Morphological changes of UG-LIKE structures in collagen I-supplemented Matrigel, with or without the allosteric collagen <t>I-binding</t> <t>integrin</t> inhibitor and <t>ROCK</t> inhibitor. Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0, 0.1, or 0.5 mg/ml bovine collagen I ( N = 5, mean ± SEM). Different superscripts indicate significant differences among collagen I concentrations, as determined by one-way ANOVA of logit-transformed data ( P < 0.05). Scale bars represent 1000 μm (A). Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0 or 0.5 mg/ml bovine collagen I, with or without 0, 10, or 50 μM allosteric collagen I-binding integrin inhibitor (TC-l 15) ( N = 5, mean ± SEM). Different superscripts indicate significant differences among experimental groups, combining collagen I supplementation and TC-l 15 treatment as a single factor, as determined by one-way ANOVA of logit-transformed data ( P < 0.05). Scale bars represent 1000 μm (B). Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0 or 0.5 mg/ml bovine collagen I, in the presence or absence of 0 or 10 μM ROCK inhibitor (Y-27632) ( N = 5, mean ± SEM). Different superscripts indicate significant differences among experimental groups, with collagen I supplementation and Y-27632 treatment as two independent factors, as determined by two-way ANOVA of logit-transformed data (Supplementary Table S4, P < 0.05). Scale bars represent 1000 μm (C).
    Y 27632 Rock Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rock+inhibitor+y+27632/Y-27632/pmc13193222-290-6-9
    Average 99 stars, based on 1 article reviews
    y 27632 rock inhibitor - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    y 27632 dihydrochloride rock inhibitor  (Tocris)
    96
    Tocris y 27632 dihydrochloride rock inhibitor
    Morphological changes of UG-LIKE structures in collagen I-supplemented Matrigel, with or without the allosteric collagen <t>I-binding</t> <t>integrin</t> inhibitor and <t>ROCK</t> inhibitor. Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0, 0.1, or 0.5 mg/ml bovine collagen I ( N = 5, mean ± SEM). Different superscripts indicate significant differences among collagen I concentrations, as determined by one-way ANOVA of logit-transformed data ( P < 0.05). Scale bars represent 1000 μm (A). Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0 or 0.5 mg/ml bovine collagen I, with or without 0, 10, or 50 μM allosteric collagen I-binding integrin inhibitor (TC-l 15) ( N = 5, mean ± SEM). Different superscripts indicate significant differences among experimental groups, combining collagen I supplementation and TC-l 15 treatment as a single factor, as determined by one-way ANOVA of logit-transformed data ( P < 0.05). Scale bars represent 1000 μm (B). Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0 or 0.5 mg/ml bovine collagen I, in the presence or absence of 0 or 10 μM ROCK inhibitor (Y-27632) ( N = 5, mean ± SEM). Different superscripts indicate significant differences among experimental groups, with collagen I supplementation and Y-27632 treatment as two independent factors, as determined by two-way ANOVA of logit-transformed data (Supplementary Table S4, P < 0.05). Scale bars represent 1000 μm (C).
    Y 27632 Dihydrochloride Rock Inhibitor, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rock+inhibitor+y+27632/Y-27632+dihydrochloride/pmc13110130-258-40-44
    Average 96 stars, based on 1 article reviews
    y 27632 dihydrochloride rock inhibitor - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    y 27632 rock inhibitor  (Nacalai)
    86
    Nacalai y 27632 rock inhibitor
    Morphological changes of UG-LIKE structures in collagen I-supplemented Matrigel, with or without the allosteric collagen <t>I-binding</t> <t>integrin</t> inhibitor and <t>ROCK</t> inhibitor. Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0, 0.1, or 0.5 mg/ml bovine collagen I ( N = 5, mean ± SEM). Different superscripts indicate significant differences among collagen I concentrations, as determined by one-way ANOVA of logit-transformed data ( P < 0.05). Scale bars represent 1000 μm (A). Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0 or 0.5 mg/ml bovine collagen I, with or without 0, 10, or 50 μM allosteric collagen I-binding integrin inhibitor (TC-l 15) ( N = 5, mean ± SEM). Different superscripts indicate significant differences among experimental groups, combining collagen I supplementation and TC-l 15 treatment as a single factor, as determined by one-way ANOVA of logit-transformed data ( P < 0.05). Scale bars represent 1000 μm (B). Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0 or 0.5 mg/ml bovine collagen I, in the presence or absence of 0 or 10 μM ROCK inhibitor (Y-27632) ( N = 5, mean ± SEM). Different superscripts indicate significant differences among experimental groups, with collagen I supplementation and Y-27632 treatment as two independent factors, as determined by two-way ANOVA of logit-transformed data (Supplementary Table S4, P < 0.05). Scale bars represent 1000 μm (C).
    Y 27632 Rock Inhibitor, supplied by Nacalai, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rock+inhibitor+y+27632/27632+y/pm42028031-342-20-23
    Average 86 stars, based on 1 article reviews
    y 27632 rock inhibitor - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Morphological changes of UG-LIKE structures in collagen I-supplemented Matrigel, with or without the allosteric collagen I-binding integrin inhibitor and ROCK inhibitor. Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0, 0.1, or 0.5 mg/ml bovine collagen I ( N = 5, mean ± SEM). Different superscripts indicate significant differences among collagen I concentrations, as determined by one-way ANOVA of logit-transformed data ( P < 0.05). Scale bars represent 1000 μm (A). Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0 or 0.5 mg/ml bovine collagen I, with or without 0, 10, or 50 μM allosteric collagen I-binding integrin inhibitor (TC-l 15) ( N = 5, mean ± SEM). Different superscripts indicate significant differences among experimental groups, combining collagen I supplementation and TC-l 15 treatment as a single factor, as determined by one-way ANOVA of logit-transformed data ( P < 0.05). Scale bars represent 1000 μm (B). Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0 or 0.5 mg/ml bovine collagen I, in the presence or absence of 0 or 10 μM ROCK inhibitor (Y-27632) ( N = 5, mean ± SEM). Different superscripts indicate significant differences among experimental groups, with collagen I supplementation and Y-27632 treatment as two independent factors, as determined by two-way ANOVA of logit-transformed data (Supplementary Table S4, P < 0.05). Scale bars represent 1000 μm (C).

    Journal: Bioscience Reports

    Article Title: Tubulogenesis of bovine uterine glands by epidermal growth factor and collagen I in 3D culture systems

    doi: 10.1042/BSR20260010

    Figure Lengend Snippet: Morphological changes of UG-LIKE structures in collagen I-supplemented Matrigel, with or without the allosteric collagen I-binding integrin inhibitor and ROCK inhibitor. Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0, 0.1, or 0.5 mg/ml bovine collagen I ( N = 5, mean ± SEM). Different superscripts indicate significant differences among collagen I concentrations, as determined by one-way ANOVA of logit-transformed data ( P < 0.05). Scale bars represent 1000 μm (A). Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0 or 0.5 mg/ml bovine collagen I, with or without 0, 10, or 50 μM allosteric collagen I-binding integrin inhibitor (TC-l 15) ( N = 5, mean ± SEM). Different superscripts indicate significant differences among experimental groups, combining collagen I supplementation and TC-l 15 treatment as a single factor, as determined by one-way ANOVA of logit-transformed data ( P < 0.05). Scale bars represent 1000 μm (B). Lengths of UG-LIKE structures on day 5 in Matrigel supplemented with 0 or 0.5 mg/ml bovine collagen I, in the presence or absence of 0 or 10 μM ROCK inhibitor (Y-27632) ( N = 5, mean ± SEM). Different superscripts indicate significant differences among experimental groups, with collagen I supplementation and Y-27632 treatment as two independent factors, as determined by two-way ANOVA of logit-transformed data (Supplementary Table S4, P < 0.05). Scale bars represent 1000 μm (C).

    Article Snippet: To further assess how collagen I influences the morphological change of 3D-cultured uterine gland fragments, a potent α1β1 and α2β1 integrin inhibitor (TC-l 15; HY-107588, MedChemExpress LLC, NJ, USA) or ROCK inhibitor (Y-27632; HY-10583, MedChemExpress LLC) was added to the culture media.

    Techniques: Binding Assay, Transformation Assay